Categories AlphaGraphs, Earnings, Health Care
CVS Health Q1 adj. earnings drop despite revenue growth; guides FY24
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced first-quarter 2024 results, reporting higher revenues and a decrease in adjusted earnings.
March-quarter adjusted profit decreased 40% year-over-year to $1.31 per share. On a reported basis, net income was $1.12 billion or $0.88 per share in Q1, compared to $2.14 billion or $1.65 per share in the prior-year quarter.
Meanwhile, revenues increased 4% year-over-year to $88.4 billion during the three months. Total same-store sales rose 5.3% from last year.
“We remain committed to our strategy and believe that we have the right assets in place to deliver value to our customers, members, patients, and shareholders,” said CVS CEO Karen Lynch.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
